"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,6,"Withdrawal from the study due to adverse events","Cenobamate (any dose)","SUBGROUP_AND_OVERALL","Chung 2020",2020,0,0,0,0,5,113,0,0,3,109,0,0,28.859045,1.60767,0.393696,6.564964,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","6::overall","CD014941_pub2_data","significance_only",TRUE,TRUE,FALSE,1.03002917820382,0.0571503741258227,0.235366047398476,1.82469230900917,-0.0240418965070339,0.138342644758679,FALSE,FALSE
1,6,"Withdrawal from the study due to adverse events","Cenobamate (any dose)","SUBGROUP_AND_OVERALL","Krauss 2020",2020,0,0,0,0,48,329,0,0,5,108,0,0,71.140955,3.151368,1.287635,7.712679,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","6::overall","CD014941_pub2_data","significance_only",TRUE,TRUE,FALSE,1.03002917820382,0.0571503741258227,0.235366047398476,1.82469230900917,-0.0240418965070339,0.138342644758679,FALSE,FALSE
1,18,"Cenobamate versus placebo - subgroup analysis, any serious adverse event","Cenobamate 200 mg","SUBGROUP_AND_OVERALL","Chung 2020",2020,0,0,0,0,2,113,0,0,4,109,0,0,40.209585,0.482301,0.090171,2.579697,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","18::overall","CD014941_pub2_data","direction_only",FALSE,FALSE,FALSE,0.0798239786403203,-0.00378765022144231,-0.53096371117519,0.690611668455831,-0.0313829384181385,0.0238076379752538,FALSE,FALSE
1,18,"Cenobamate versus placebo - subgroup analysis, any serious adverse event","Cenobamate 200 mg","SUBGROUP_AND_OVERALL","Krauss 2020",2020,0,0,0,0,4,110,0,0,6,108,0,0,59.790415,0.654545,0.189988,2.255033,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","18::overall","CD014941_pub2_data","direction_only",FALSE,FALSE,FALSE,0.0798239786403203,-0.00378765022144231,-0.53096371117519,0.690611668455831,-0.0313829384181385,0.0238076379752538,FALSE,FALSE
1,18,"Cenobamate versus placebo - subgroup analysis, any serious adverse event","Cenobamate 400 mg","SUBGROUP_AND_OVERALL","Krauss 2020",2020,0,0,0,0,8,111,0,0,6,108,0,0,100,1.297297,0.465551,3.615028,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","18::overall","CD014941_pub2_data","direction_only",FALSE,FALSE,FALSE,0.0798239786403203,-0.00378765022144231,-0.53096371117519,0.690611668455831,-0.0313829384181385,0.0238076379752538,FALSE,FALSE
1,18,"Cenobamate versus placebo - subgroup analysis, any serious adverse event","Cenobamate 100 mg","SUBGROUP_AND_OVERALL","Krauss 2020",2020,0,0,0,0,10,108,0,0,6,108,0,0,100,1.666667,0.627809,4.424562,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014941.pub2/full","10.1002/14651858.CD014941.pub2","18::overall","CD014941_pub2_data","direction_only",FALSE,FALSE,FALSE,0.0798239786403203,-0.00378765022144231,-0.53096371117519,0.690611668455831,-0.0313829384181385,0.0238076379752538,FALSE,FALSE
